Skip to main content
SpringerLink
Log in

500 Intragastric Balloons: What Happens 5 Years Thereafter?

  • Clinical Research
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

The BioEnterics Intragastric Balloon (BIB) has been considered an effective, less invasive method for weight loss, as it provides a permanent sensation of satiety. However, various non-randomized studies suggest BIB is a temporary anti-obesity treatment, which induces only a short-term weight loss. The purpose of this study was to present data of 500 obese who, after BIB-induced weight reduction, were followed up for up to 5 years.

Methods

The BioEnterics BIB was used, and remained for 6 months. At 6, 12, and 24 months post-removal (and yearly thereafter), all subjects were contacted for follow-up.

Results

From 500 patients enrolled, 26 were excluded (treatment protocol interruption); 474 thus remained, having initial body weight of 126.16 ± 28.32 kg, BMI of 43.73 ± 8.39 kg/m2, and excess weight (EW) of 61.35 ± 25.41. At time of removal, 79 (17%) were excluded as having percent excessive weight loss (EWL) of <20%; the remaining 395 had weight loss of 23.91 ± 9.08 kg (18.73%), BMI reduction of 8.34 ± 3.14 kg/m2 (18.82%), and percent EWL of 42.34 ± 19.07. At 6 and 12 months, 387 (98%) and 352 (89%) presented with weight loss of 24.14 ± 8.93 and 16.31 ± 7.41 kg, BMI reduction of 8.41 ± 3.10 and 5.67 ± 2.55 kg/m2, and percent EWL of 42.73 ± 18.87 and 27.71 ± 13.40, respectively. At 12 and 24 months, 187 (53%) and 96 (27%) of 352 continued to have percent EWL of >20. Finally, 195 of 474 who completed the 60-month follow-up presented weight loss of 7.26 ± 5.41 kg, BMI reduction of 2.53 ± 1.85 kg/m2, and percent EWL of 12.97 ± 8.54. At this time, 46 (23%) retained the percent EWL at >20. In general, those who lost 80% of the total weight lost during the first 3 months of treatment succeeded in maintaining a percent EWL of >20 long term after BIB removal: more precisely, this cutoff point was achieved in 83% at the time of removal and in 53%, 27%, and 23% at 12-, 24-, and 60-month follow-up.

Conclusion

BIB seems to be effective for significant weight loss and maintenance for a long period thereafter, under the absolute prerequisite of patient compliance and behavior change from the very early stages of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: WHO; 1998

  2. Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. J Am Med Assoc. 1999;1999(282):1530–8.

    Article  Google Scholar 

  3. Health benefits of weight loss. In: www.maso.org.my/spom/chap4.pdf.

  4. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Obes Res 1998; 6: 51S–209S.

    Google Scholar 

  5. Bays HE. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res. 2004;12:1197–211.

    Article  PubMed  CAS  Google Scholar 

  6. Waseem T, Mogensen KM, Lautz DB, et al. Pathophysiology of obesity: why surgery remains the most effective treatment. Obes Surg. 2007;17:1389–98.

    Article  PubMed  Google Scholar 

  7. Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007;107:1755–67.

    Article  PubMed  Google Scholar 

  8. Avenell A, Brown TJ, McGee MA, et al. What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions. J Hum Nutr Diet. 2004;17:293–316.

    Article  PubMed  CAS  Google Scholar 

  9. Curioni CC, Lourenço PM. Long-term weight loss after diet and exercise: a systematic review. Int J Obes. 2005;29:1168–74.

    Article  CAS  Google Scholar 

  10. Rossi A, Bersani G, Ricci G, et al. Intragastric balloon insertion increases the frequency of erosive esophagitis in obese patients. Obes Surg. 2007;17:1346–9.

    Article  PubMed  Google Scholar 

  11. Kotzampassi K, Eleftheriadis E. Intragastric balloon as an alterantive procedure for morbid obesity. Ann Gastroenterol. 2006;19:285–8.

    Google Scholar 

  12. Doldi SB, Micheletto G, Di Prisco F, et al. Intragastric balloon in obese patients. Obes Surg. 2000;10:578–81.

    Article  PubMed  CAS  Google Scholar 

  13. Kotzampassi K, Shrewsbury AD. Intragastric balloon: ethics, medical need and cosmetics. Dig Dis. 2008;26:45–8.

    Article  PubMed  Google Scholar 

  14. Melissas J. IFSO guidelines for safety, quality, and excellence in bariatric surgery. Obes Surg. 2008;18:497–500.

    Article  PubMed  Google Scholar 

  15. Wahlen CH, Bastens B, Herve J, et al. The BioEnterics Intragastric Balloon (BIB): how to use it. Obes Surg. 2001;11:524–7.

    Article  PubMed  CAS  Google Scholar 

  16. Schapiro M, Benjamin S, Blackburn G, et al. Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19–21, 1987. Gastrointest Endosc. 1987;33:323–7.

    Article  PubMed  CAS  Google Scholar 

  17. Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19:1084–8.

    Article  PubMed  Google Scholar 

  18. Imaz I, Martínez-Cervell C, García-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6.

    Article  PubMed  Google Scholar 

  19. Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20:1128–32.

    Article  PubMed  Google Scholar 

  20. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19–27.

    Article  PubMed  Google Scholar 

  21. Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70.

    Article  PubMed  CAS  Google Scholar 

  22. Mion F, Gincul R, Roman S, et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study. Obes Surg. 2007;17:764–9.

    Article  PubMed  Google Scholar 

  23. Deitel M. How much weight loss is sufficient to overcome major co-morbidities? Obes Surg. 2001;11:659.

    Article  PubMed  CAS  Google Scholar 

  24. Spyropoulos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis. 2007;3:78–83.

    Article  PubMed  Google Scholar 

  25. Mathus-Vliegen EM. Intragastric balloon treatment for obesity: what does it really offer? Dig Dis. 2008;26:40–4.

    Article  PubMed  Google Scholar 

  26. Dumonceau JM, François E, Hittelet A, et al. Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study. Obes Surg. 2010;20:692–7.

    Article  PubMed  Google Scholar 

  27. Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics® Intragastric Balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg. 2011;21:5–9.

    Article  PubMed  Google Scholar 

  28. Dastis NS, François E, Deviere J, et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy. 2009;41:575–80.

    Article  PubMed  Google Scholar 

  29. Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611–7.

    Article  PubMed  Google Scholar 

  30. Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14:991–8.

    Article  PubMed  Google Scholar 

  31. Al-Momen A, El-Mogy I. Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2005;15:101–5.

    Article  PubMed  Google Scholar 

  32. Totté E, Hendrickx L, Pauwels M, et al. Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon. Obes Surg. 2001;11:519–23.

    Article  PubMed  Google Scholar 

  33. Fernandes M, Atallah AN, Soares BG, Humberto S, Guimarães S, Matos D, Monteiro L, Richter B. Intragastric balloon for obesity. Cochrane Database Syst Rev. 2007;(1):CD004931

Download references

Conflict of Interest

All contributing authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Surgery, Aristotle’s University of Thessaloniki, 54632, Thessaloniki, Greece

    Katerina Kotzampassi, Vasilis Grosomanidis, Pyrros Papakostas, Sofia Penna & Efthymios Eleftheriadis

Authors
  1. Katerina Kotzampassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vasilis Grosomanidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pyrros Papakostas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sofia Penna
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Efthymios Eleftheriadis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katerina Kotzampassi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kotzampassi, K., Grosomanidis, V., Papakostas, P. et al. 500 Intragastric Balloons: What Happens 5 Years Thereafter?. OBES SURG 22, 896–903 (2012). https://doi.org/10.1007/s11695-012-0607-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-012-0607-2

Keywords

Search

Navigation